Jeremy J. Flood, MD

Diabetes, Endocrinology
Accepting new patients
Sees patients age 18 and up
Penn Endocrinology and Diabetes University City
Schedule onlineCall 215-662-9905
Headshot of Jeremy J. Flood, MD
Penn Medicine Provider

About me

  • Chief, Division of Endocrinology, Penn Presbyterian Medical Center
  • Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)

My education and training

  • Medical School: State University of New York at Buffalo
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: Thomas Jefferson University Hospital

Reviews

Average Rating

401 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
he is a great doctor
Anonymous
May 2026
he's very personable like him alot
Anonymous
April 2026
great doctor!
Anonymous
April 2026
caring and knowledgeable

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Flood is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Hvisdas CM, Goode ND, Kim DH, Silvey MJ, Flood JJ Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report , Endocrine Practice, 31(1): 2025,59-64

Passman J, Hwang J MD MS, Tang J, Epps M, Chambers C, Cook T, Fagan M, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Kelz RR, Herman DS. Development of Comprehensive Decision Support to Improve Screening for Primary Hyperparathyroidism. , Oral podium presentation at Nudges in Health Care Symposium in Philadelphia, PA.: 2024

Hwang J, Passman J, Tang T, Fagen M, Epps M, Chambers C, Cook T, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Herman DS, Kelz RR. Electronic Medical Record-Based Behavioral Nudges to Improve Screening Rates for Primary Hyperparathyroidism. , Oral podium and poster presentation. Presented at American College of Surgeons Quality and Safety Conference in Denver, CO.: 2024

Jesse M. Raiten, Andrea Morlok, Sarah D'Ambrosia, Michael A. Ruggero, Jeremy Flood Perioperative Management of Patients Receiving Sodium Glucose Co-Transporter-2 Inhibitors: Development of a Clinical Guideline at a Large Academic Medical Center , Journal of Cardiothoracic and Vascular Anesthesia, 38(1): 2024,57-66

Passman J, Hwang J, Fagen M, Epps M, Peifer M, Flood J, Nicklin D, Delgado MK, Kelz R, Herman D Electronic health record-based nudges to enhance screening rates for primary hyperparathyroidism: a pilot study , Nudges in Health Care Symposium: 2023

Jo Kamimoto, Jorge L.; Flood, Jeremy J. Systemic Thyroid Dysfunction in Graves Disease , International Ophthalmology Clinics, 63(2): 2023,55-63

L McLeer Maloney, J Flood, N Alamuddin, M Al Mukaddam Findings from a Diabetes Support Group—A Pilot Study , Diabetes, 67(Supplement 1): 2018,720

Simon B, Flood J, Jabbour S Type 1 Diabetes in Adults , Oxford American Endocrinology Library : 2011

Flood JJ, Miller JL. Treatment of Type 2 Diabetes Mellitus with Oral Agents , A Case-based Guide to Clinical Endocrinology: 2008,359-365

Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ. Dual PPAR alpha/gamma Agonists: Promises and Pitfalls in Type 2 Diabetes , American Journal of Therapeutics, 14: 2007,49-62